Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 486460-00-8
2. (r)-3-((tert-butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic Acid
3. (3r)-n-(tert-butoxycarbonyl)-3-amino-4-(2,4,5-trifluorophenyl)butanoic Acid
4. (3r)-3-[(2-methylpropan-2-yl)oxycarbonylamino]-4-(2,4,5-trifluorophenyl)butanoic Acid
5. Boc-(r)-3-amino-4-(2,4,5-trifluoro-phenyl)-butyric Acid
6. 2s9nwb23qs
7. C15h18f3no4
8. (3r)-3-(tert-butoxycarbonylamino)-4-(2,4,5-trifluorophenyl)butanoic Acid
9. (r)-n-boc-3-amino-4-(2,4,5-trifluorophenyl)butanoic Acid
10. (3r)-3-[(tert-butoxycarbonyl)amino]-4-(2,4,5-trifluorophenyl)butanoic Acid
11. (3r)-3-[(1,1-dimethylethoxycarbonyl)amino]-4-(2,4,5-trifluorophenyl)butanoic Acid
12. N-boc-(r)-3-amino-4-(2,4,5-trifluorophenyl)butanoic Acid
13. (r)-3-(tert-butoxycarbonylamino)-4-(2,4,5-trifluorophenyl) Butanoic Acid
14. (3r)-3-{[(tert-butoxy)carbonyl]amino}-4-(2,4,5-trifluorophenyl)butanoic Acid
15. Mfcd06659147
16. (r)-3-[(tert-butoxycarbonyl)amino]-4-(2,4,5-trifluorophenyl)butanoic Acid
17. Sitagliptin Impurity 19
18. Unii-2s9nwb23qs
19. (r)-3-(tert-butoxycarbonylamino)-4-(2,4,5-trifluorophenyl)butanoic Acid
20. Schembl342707
21. N-boc Sitagliptin Acid Impurity
22. Amy6934
23. Boc-(r)-3-amino-4-(2,4,5-trifluorophenyl)butyric Acid
24. Dtxsid70428050
25. Bcp22635
26. Cs-m3237
27. Zinc4242022
28. Akos016842487
29. Ac-1034
30. Mg-0718
31. 460b008
32. N-boc-(r)-2,4,5-trifluoro-beta-homophenylalanine
33. Q-102524
34. Q-102792
35. (r)-boc-3-amino-4-(2,4,5-trifluorophenyl) Butanoic Acid
36. (boc-(r)-3-amino-4-(2,4,5-trifluorophenyl) Butanoic Acid)
37. (r)-3-t-butoxycarbonylamino-4-(2,4,5-trifluorophenyl)-butyric Acid
38. (r)-3-t-butoxycarbonylamino-4-(2,4,5-trifluorophenyl)butanoic Acid
39. (3r)-3-[(tert-butoxycarbonyl)amino]4-(2,4,5-trifluorophenyl)butanoic Acid
40. (3r)-3-tert-butoxycarbonylamino-4-(2,4,5-trifluoro-phenyl)-butanoic Acid
41. (r)-3-((t-butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic Acid
42. (r)-3-((tert-butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoicacid
43. (r)-3-(t-butoxycarbonylamino)-4-(2,4,5-trifluorophenyl)butanoic Acid
44. (r)-3-(tert-butoxycarbonylamino)-4-(2,4,5-trifluorophenyl)n-butyric Acid
45. (r)-3-tert-butoxycarbonylamino-4-(2,4,5-trifluoro-phenyl)-butyric Acid
46. 3(r)-tert-butoxycarbonylamino-4-(2,4,5-trifluoro-phenyl)-butyric Acid
47. (3r)-3-[(1,1-dimethylethoxycarbonyl)amino]4(2,4,5-trifluorophenyl)butanoic Acid
48. (3r)-3-[(1,1-dimethylethoxycarbonyl)amino]4-(2,4,5-trifluorophenyl)butanoic Acid
49. (3r)-3-[n-(tert-butoxycarbonyl)amino]-4-(2,4,5-trifluorophenyl)butanoic Acid
50. (3r)-n-tert-butoxycarbonyl)-3-amino-4-(2,4,5-trifluorophenyl) Butanoic Acid
51. (r)-3-[(tert-butoxycarbonyl) Amino]-4-(2,4,5-trifluorophenyl)butanoic Acid
52. (r)-3-[(tert-butoxycarbonyl)amino]-4-(2,4,5-trifluoro-phenyl)butanoic Acid
53. (r)-3-[(tert-butyloxycarbonyl)amino]-4-(2,4,5-trifluorophenyl)butanoic Acid
54. (r)-3-[n-(tert-butoxycarbonyl)amino]-4-(2,4,5-trifluorophenyl)butanoic Acid
55. (r)-n-(tert-butoxycarbonyl)-3-amino-4-(2,4,5-trifluorophenyl)butanoic Acid
56. (r)-3-(tert-butoxycarbonyl)-4-(2,4,5-trifluorophenyl)butanoic Acid;(r)-3-((tert-butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic Acid
57. Benzenebutanoic Acid, .beta.-(((1,1-dimethylethoxy)carbonyl)amino)-2,4,5-trifluoro-, (.beta.r)-
58. Benzenebutanoic Acid, Beta-(((1,1-dimethylethoxy)carbonyl)amino)-2,4,5-trifluoro-, (betar)-
Molecular Weight | 333.30 g/mol |
---|---|
Molecular Formula | C15H18F3NO4 |
XLogP3 | 2.7 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 7 |
Exact Mass | 333.11879254 g/mol |
Monoisotopic Mass | 333.11879254 g/mol |
Topological Polar Surface Area | 75.6 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 427 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
98
PharmaCompass offers a list of 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid manufacturer or 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid manufacturer or 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid supplier.
PharmaCompass also assists you with knowing the 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid API Price utilized in the formulation of products. 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid API Price is not always fixed or binding as the 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid Price is obtained through a variety of data sources. The 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid, including repackagers and relabelers. The FDA regulates 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid supplier is an individual or a company that provides 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid active pharmaceutical ingredient (API) or 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid finished formulations upon request. The 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid suppliers may include 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid API manufacturers, exporters, distributors and traders.
click here to find a list of 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid DMF (Drug Master File) is a document detailing the whole manufacturing process of 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid active pharmaceutical ingredient (API) in detail. Different forms of 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid DMFs exist exist since differing nations have different regulations, such as 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid DMF submitted to regulatory agencies in the US is known as a USDMF. 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid USDMF includes data on 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid suppliers with USDMF on PharmaCompass.
3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid GMP manufacturer or 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid GMP API supplier for your needs.
A 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid CoA (Certificate of Analysis) is a formal document that attests to 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid's compliance with 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid specifications and serves as a tool for batch-level quality control.
3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid CoA mostly includes findings from lab analyses of a specific batch. For each 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid may be tested according to a variety of international standards, such as European Pharmacopoeia (3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid EP), 3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (3R-N-Tert-Butoxycarbonyl-3-Amino-4-2,4,5-Trifluorophenyl-Butanoic Acid USP).